Overview

Human Factors Study to Validate the User Interface of TOBI Podhaler Using Placebo Capsules

Status:
Completed
Trial end date:
2019-06-17
Target enrollment:
Participant gender:
Summary
The purpose of this study is to validate the user interface of TOBI Podhaler by establishing that the product can support safe and effective use for the intended users
Phase:
Phase 4
Details
Lead Sponsor:
Mylan Inc.
Novartis Pharmaceuticals
Treatments:
Tobramycin